Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine and acetaminophen for postictal symptoms after ECT
NL-OMON48237Phase 2Recruiting
- Sponsor
- Rijnstate
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nimodipine and acetaminophen in None (3 arms), sponsored by Rijnstate. Primary endpoint: Time to EEG normalization. Started Dec 2019; status: recruiting.
02
Drugs
nimodipineacetaminophen
Beyond the preview
Go deeper on NL-OMON48237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48237.